Co-Owner
CurrentDog Star Technologies is co-founded by Dr. Gregory Berns, MD, PhD, the Chair of the Emory Center for Neuroeconomics and Neuropolicy and Mark Spivak, the President of Comprehensive Pet Therapy (CPT). Dog Star's primary mission is to conduct government and privately funded canine neuroscience research that increases the understanding of canine cognition, emotions, sensory reception, receptive communication, and inhibitory control. The company has received a $1 million contract from DARPA to… Show more Dog Star Technologies is co-founded by Dr. Gregory Berns, MD, PhD, the Chair of the Emory Center for Neuroeconomics and Neuropolicy and Mark Spivak, the President of Comprehensive Pet Therapy (CPT). Dog Star's primary mission is to conduct government and privately funded canine neuroscience research that increases the understanding of canine cognition, emotions, sensory reception, receptive communication, and inhibitory control. The company has received a $1 million contract from DARPA to study fMRI biomarkers and electronic activity sensors that improve the identification of candidate service dogs. Secondary corporate missions and business functions include: 1) neuroimaging and neuromarketing services that improve product development, product testing, and strategic marketing practices for large pet food and pet supply manufacturers. Dog Star's noninvasive fMRI protocols provide an empirical, real-time measurement of canine olfactory, gustatory, and anticipatory reward responses pertinent to the development, testing, and marketing of canine food and toy products. 2) Developing canine imaging protocols that improve veterinary neurological medicine. Dog Star is the world's leader in developing awake, non-restrained canine fMRI processes. Such processes potentially provide great value in diagnosing and better understanding canine neurological conditions. 3) Facilitating the testing of canine psychopharmaceutical medication. Dog Star's awake, nonrestrained fMRI protocols can aid pharmaceutical companies in objectively testing the CNS effects of psychotropic medication. 4) Developing and commercializing canine performance products, especially products that relieve canine state anxiety, including separation, thunderstorm, and noise anxiety, and anxiety that results in reactive aggressive behavior. Dog Star has several products in the concept stage.The company is presently seeking investment funding via grants, private investment, and venture capital. Show less